Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Shortages and supply disruptions (16)
- Safety monitoring and information (127)
- Compliance and enforcement (33)
- Import and export (31)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
477 result(s) found, displaying 226 to 250
-
Market actionsRecall - risk of adverse events due to unacceptably high level of arsenic
-
Safety alertsUpdate - adverse event monitoring
-
Market actionsThe following medicines (with brand names in brackets) should be returned to a pharmacy: alprazolam (Xanax), cabergoline (Dostinex and Cabaser), mefanamic acid (Ponstan), methotrexate (Methoblastin) and triazolam (Halcion)
-
Market actionsRecall - bottles supplied without child-resistant caps
-
-
-
-
-
-
-
-
-
-
-
-
Safety alertsSafety advisory
-
-
Market actionsRecall for product correction - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Market actionsRecall for product correction - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Market actionsRecall - bottles supplied without child-resistant caps
-
Safety alertsConsumers are advised not to purchase Bright Eyes products being offered for sale on the internet
-
Safety alertsFor the 2015 influenza season, the following trivalent and quadrivalent influenza vaccines will be registered and available for use
-